Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study - Tseng, H. F.; Liu, A.; Sy, L.; Marcy, S. M.; Fireman, B.; Weintraub, E.; Baggs, J.; Weinmann, S.; Baxter, R.; Nordin, J.; Daley, M. F.; Jackson, L.; et al. (Journal of internal medicine, 2012)
Keywords: adult vaccination; Adverse Drug Reaction Reporting Systems - statistics & numerical data; Aged; Aged, 80 and over; Biological and medical sciences; Cardiovascular Diseases - etiology; Cardiovascular Diseases - immunology; case-centered method; Cohort Studies; Female; General aspects; Herpes Zoster - epidemiology; Herpes Zoster - immunology; Herpes Zoster - prevention & control; herpes zoster vaccine; Herpes Zoster Vaccine - administration & dosage; Herpes Zoster Vaccine - adverse effects; Humans; Hypersensitivity - etiology; Hypersensitivity - immunology; Male; Medical sciences; Middle Aged; Miscellaneous; Nervous System Diseases - etiology; Nervous System Diseases - immunology; Population Surveillance; Prevention and actions; Public health. Hygiene; Public health. Hygiene-occupational medicine; Risk Assessment; self-controlled case series; Time Factors; United States - epidemiology; varicella zoster virus; United States; Skin disease; Methodology; Managed care; Toxicity; Vaccination; Alphaherpesvirinae; Self; Prevention; self-controlled case series; Cohort study; herpes zoster vaccine; Adult; Safety; case-centered method; Public health; Human; Varicella zoster virus; adult vaccination; Nervous system diseases; Center; Herpes zoster; Herpesviridae; Vaccine; Method; Pharmacovigilance; Infection; Virus; Medicine; Immunoprophylaxis; Viral disease